Drug recall · January 23, 2019
Cephalexin for Oral Suspension USP recall
Why: CGMP Deviation; manufacturing batch record could not be located
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Cephalexin for Oral Suspension USP, 250mg/5mL, 200 mL (when mixed), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland, Manufactured by: Lupin Limited, Mandideep, India ---- NDC 68180-0124-02
- Lots / codes
lot # F602820, Expiry December 2019
- Quantity
- 7,215 bottles
- Company
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Distribution
- Product was distributed to 12 major distributors who may have further distributed the product throughout the United States.
- Initiated
- January 7, 2019 · Voluntary: Firm initiated
- Classified
- January 16, 2019
- Reported
- January 23, 2019
- Ended
- July 8, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cephalexin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.